Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Vaccinex
Market Cap: US$2.8m
A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.
VCNX
US$1.04
7D
52.9%
1Y
-81.2%
Itoco
Market Cap: US$2.8m
Engages in the processing, production, and distribution of medical cannabis products.
ITMC
US$0.0065
7D
0%
1Y
30.0%
Nuformix
Market Cap: UK£2.1m
Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.
NFX
UK£0.0013
7D
-3.8%
1Y
-32.4%
Revelation Biosciences
Market Cap: US$2.8m
Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.
REVB
US$3.05
7D
-4.0%
1Y
-90.6%
Spruce Biosciences
Market Cap: US$2.7m
A biopharmaceutical company, focuses on developing and commercializing novel therapies for neurological disorders.
SPRB
US$0.065
7D
-13.0%
1Y
-91.3%
Awakn Life Sciences
Market Cap: CA$4.0m
A biotechnology company, engages in the research, development, operation, and delivery of psychedelic therapeutics to treat addiction and other mental health conditions in North America and Europe.
AWKN
CA$0.095
7D
0%
1Y
-26.9%
Akanda
Market Cap: US$2.7m
Through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide.
AKAN
US$1.20
7D
3.4%
1Y
-91.3%
Marvel Biosciences
Market Cap: CA$3.8m
A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.
MRVL
CA$0.085
7D
-5.6%
1Y
-5.6%
Scinai Immunotherapeutics
Market Cap: US$2.7m
A development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases in Israel.
SCNI
US$2.91
7D
12.8%
1Y
-35.3%
Xebra Brands
Market Cap: CA$3.8m
Engages in the cultivation, processing, manufacture, design, and delivery of cannabis products in Canada, Europe, and Mexico.
XBRA
CA$0.045
7D
12.5%
1Y
-55.0%
IQ-AI
Market Cap: UK£2.0m
Through its subsidiaries, provides clinical treatments to patients in the field of medical imaging diagnostics primarily in the United States.
IQAI
UK£0.0083
7D
-2.9%
1Y
-44.3%
Catheter Precision
Market Cap: US$2.7m
Designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States.
VTAK
US$0.29
7D
1.4%
1Y
-95.0%
Galmed Pharmaceuticals
Market Cap: US$2.7m
A biopharmaceutical company, focuses on the development of Aramchol for the treatment of liver diseases.
GLMD
US$1.19
7D
-4.0%
1Y
-75.5%
QHSLab
Market Cap: US$2.7m
A medical device technology and software-as-a-service SaaS company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine including digital therapeutics.
USAQ
US$0.24
7D
39.9%
1Y
101.3%
Theriva Biologics
Market Cap: US$2.7m
A clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States.
TOVX
US$0.56
7D
5.5%
1Y
-94.0%
Tivic Health Systems
Market Cap: US$2.6m
Operates as a health tech company, develops and commercializes bioelectronic medicine.
TIVC
US$4.27
7D
8.4%
1Y
-46.7%
Patrys
Market Cap: AU$4.1m
Develops and commercializes antibody technologies for the treatment of cancer in Australia.
PAB
AU$0.002
7D
-33.3%
1Y
-73.3%
NLS Pharmaceutics
Market Cap: US$2.6m
A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders.
NLSP
US$1.62
7D
-1.5%
1Y
-75.4%
ValiRx
Market Cap: UK£2.0m
A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.
VAL
UK£0.0053
7D
-4.5%
1Y
-76.1%
Appili Therapeutics
Market Cap: CA$3.6m
A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.
APLI
CA$0.03
7D
0%
1Y
-14.3%
Escalon Medical
Market Cap: US$2.6m
Engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally.
ESMC
US$0.35
7D
88.5%
1Y
74.4%
AVVAA World Health Care Products
Market Cap: US$2.6m
Provides natural and therapeutic skin care products worldwide.
AVVH
US$0.0027
7D
0.8%
1Y
97.8%
Talis Biomedical
Market Cap: US$2.6m
Operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States.
TLIS
US$1.41
7D
-11.9%
1Y
-84.3%
Biotron
Market Cap: AU$4.0m
A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.
BIT
AU$0.003
7D
0%
1Y
-94.5%
Ridder Titan Genesis
Market Cap: US$2.5m
A medical marijuana company, focuses on the development of whole plant extractions for the cancer and palliative treatments.
RTGC
US$0.38
7D
52.0%
1Y
-20.8%
Freedom Care Group Holdings
Market Cap: AU$4.0m
Provides care and support services to individuals with disabilities in Australia.
FCG
AU$0.037
7D
0%
1Y
-76.9%
Psykey
Market Cap: US$2.5m
Engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life.
CEOS
US$0.0075
7D
-30.0%
1Y
-52.5%
Intelicare Holdings
Market Cap: AU$3.9m
Engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia.
ICR
AU$0.008
7D
0%
1Y
-27.3%
Alzamend Neuro
Market Cap: US$2.5m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$3.40
7D
-42.6%
1Y
-94.0%
Megola
Market Cap: US$2.5m
Develops and sells various physical water treatment devices.
MGON
US$0.0085
7D
0%
1Y
23.2%
Can B
Market Cap: US$2.5m
Develops, manufactures, and sells hemp biomass derived products containing cannabinoids.
CANB
US$0.028
7D
-23.4%
1Y
19.6%
Stem Cell Authority
Market Cap: US$2.4m
A technology development company, focuses on the collection and cryogenic preservation of stem cells.
SCAL
US$0.0002
7D
0%
1Y
-93.8%
THC Biomed Intl
Market Cap: CA$3.3m
Produces and sells medical and recreational cannabis in Canada.
THC
CA$0.02
7D
0%
1Y
-50.0%
AXIM Biotechnologies
Market Cap: US$2.4m
Engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases.
AXIM
US$0.0072
7D
-7.7%
1Y
-28.5%
Bone Biologics
Market Cap: US$2.4m
A medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein.
BBLG
US$0.72
7D
-3.8%
1Y
-61.6%
One World Products
Market Cap: US$2.3m
One World Products, Inc. intends to produce raw cannabis and hemp plant ingredients for medical and industrial uses.
OWPC
US$0.022
7D
5.2%
1Y
-62.2%